NCT04892888View on ClinicalTrials.gov

Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

August 1, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Coronavirus Disease (COVID-19)
Interventions
BIOLOGICAL

COVID-19 Vaccine

COVID-19 Vaccine Intramuscular Injection

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY